Table 2.

Comparison between glaucoma patients with disc hemorrhage who showed visual field progression or remained stable during the follow-up period.

Variables	Progression (n = 45)	Stable (n = 53)	P Value
Age at diagnosis (yrs)	61.62 ± 12.21	60.26 ± 12.07	0.582*
Male, no. (%)	22 (41.5%)	14 (31.1%)	0.197†
Systemic factors, no (%)
Diabetes mellitus	8 (17.8%)	10 (18.9%)	0.551†
Hypertension	11 (24.4%)	14 (26.4%)	0.505†
Medication of aspirin	11 (24.4%)	13 (24.5%)	0.590†
SE refraction error (D)	−1.51 ± 3.19	−0.78 ± 2.75	0.389*
Axial length (mm)	24.20 ± 1.47	24.10 ± 1.87	0.846*
Central corneal thickness (μm)	519.05 ± 39.21	531.62 ± 31.45	0.234*
Baseline IOP (mmHg)	14.82 ± 3.57	15.55 ± 3.14	0.337*
Mean follow-up IOP (mmHg)	14.04 ± 2.92	14.52 ± 2.36	0.367*
Peak follow-up IOP (mmHg)	15.66 ± 3.35	15.75 ± 3.07	0.885*
IOP fluctuation (mmHg)	4.35 ± 1.63	4.17 ± 4.59	0.583*
Optic disc characteristics
Disc area (mm2)	2.20 ± 0.51	2.14 ± 0.38	0.547*
Average RNFL thickness (μm)	79.82 ± 12.74	79.97 ± 10.84	0.950*
Number of DH	2.15 ± 1.10	2.11 ± 1.08	0.849*
Recurrent DH, no (%)	29 (64.4%)	33 (62.3%)	0.495*
Number of eyes with focal LC defect, no (%)	26 (57.8%)	10 (18.9%)	<0.001 †
Focal LC defect at the DH site, no (%)	17 (37.8%)	3 (5.7%)	0.001 †
Focal LC defect outside the DH site, no (%)	9 (20.0%)	7 (13.2%)	0.263
Baseline VF examination	−4.22 ± 3.69	−3.77 ± 4.91	0.654*
MD (dB)	4.31 ± 3.69	4.84 ± 3.86	0.499*
PSD (dB)	72.29 ± 12.24	72.64 ± 12.16	0.161*
Follow-up duration (mos)

D, diopters; IOP, intraocular pressure; RNFL, retinal nerve fiber layer; DH, disc hemorrhage; LC, lamina cribrosa; MD, mean deviation; PSD, pattern standard deviation; VF, visual field.

^*Student t-test.

^†Chi-square test.

Data are mean ± standard deviation unless otherwise indicated.

Factors with statistical significance are shown in bold.